SEHK:1801Biotechs
Assessing Innovent Biologics (SEHK:1801) Valuation Following Strong Share Price Momentum
Innovent Biologics (SEHK:1801) shares have shown some movement recently, drawing the attention of investors interested in the biotech space. With steady revenue and net income growth over the past year, there are clear factors to watch in this situation.
See our latest analysis for Innovent Biologics.
With a share price sitting at HK$92.0, Innovent Biologics has seen impressive momentum this year, as shown by a 159.15% year-to-date share price return and a 147.98% total shareholder return...